ASX - Delayed Quote AUD
Vita Life Sciences Limited (VLS.AX)
1.8500
0.0000
(0.00%)
As of 10:09:07 AM GMT+10. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
6,155
6,155
12,982
2,775
5,889
Investing Cash Flow
-198
-198
-660
-139
-155
Financing Cash Flow
-2,992
-2,992
-2,875
-3,105
-4,389
End Cash Position
28,601
28,601
24,630
15,688
15,893
Income Tax Paid Supplemental Data
3,355
3,355
3,336
4,326
2,882
Interest Paid Supplemental Data
209
209
135
34
104
Capital Expenditure
-198
-198
-660
-139
-155
Issuance of Capital Stock
3,856
3,856
871
582
40
Repayment of Debt
--
--
--
-338
-1,534
Repurchase of Capital Stock
-1,393
-1,393
-208
-311
--
Free Cash Flow
5,957
5,957
12,322
2,636
5,734
12/31/2021 - 7/8/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
002755.SZ Beijing Aosaikang Pharmaceutical Co., Ltd.
17.31
+0.17%
300723.SZ ApicHope Pharmaceutical Group Co., Ltd.
36.35
+0.19%
LDBA.SG H. Lundbeck AS
4.3800
+9.83%
688506.SS Sichuan Biokin Pharmaceutical Co.,Ltd.
268.00
+1.38%
TRILC.IS Turk Ilac Ve Serum Sanayi Anonim Sirketi
20.62
+0.49%
MRK.SG Merck KGaA
124.00
-1.35%
LDBB.SG H. Lundbeck AS
3.7000
+5.87%
4507.T Shionogi & Co., Ltd.
2,198.00
-0.43%
IMCC.CN IM Cannabis Corp.
2.2700
-3.40%
AGY.L Allergy Therapeutics plc
7.00
+1.45%